DK3432899T3 - Anvendelse af probiotika ved behandling og/eller forebyggelse af psoriasis - Google Patents

Anvendelse af probiotika ved behandling og/eller forebyggelse af psoriasis Download PDF

Info

Publication number
DK3432899T3
DK3432899T3 DK17722689.1T DK17722689T DK3432899T3 DK 3432899 T3 DK3432899 T3 DK 3432899T3 DK 17722689 T DK17722689 T DK 17722689T DK 3432899 T3 DK3432899 T3 DK 3432899T3
Authority
DK
Denmark
Prior art keywords
probiotics
psoriasis
prevention
treatment
Prior art date
Application number
DK17722689.1T
Other languages
English (en)
Inventor
López Vicente Manuel Navarro
Boscá Ana Adela Ramírez
Orquín José Manuel Pérez
Vidal Daniel Ramón
Martínez Salvador Genovés
Cuadros María Empar Chenoll
Cortés Francisco Manuel Codoñer
Original Assignee
Biopolis SL
Bionou Res S L
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Biopolis SL, Bionou Res S L filed Critical Biopolis SL
Application granted granted Critical
Publication of DK3432899T3 publication Critical patent/DK3432899T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A61K35/745—Bifidobacteria
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K10/00—Animal feeding-stuffs
    • A23K10/10—Animal feeding-stuffs obtained by microbiological or biochemical processes
    • A23K10/16—Addition of microorganisms or extracts thereof, e.g. single-cell proteins, to feeding-stuff compositions
    • A23K10/18—Addition of microorganisms or extracts thereof, e.g. single-cell proteins, to feeding-stuff compositions of live microorganisms
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/135—Bacteria or derivatives thereof, e.g. probiotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A61K35/747—Lactobacilli, e.g. L. acidophilus or L. brevis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/06—Fungi, e.g. yeasts
    • A61K36/062—Ascomycota
    • A61K36/064—Saccharomycetales, e.g. baker's yeast
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2200/00—Function of food ingredients
    • A23V2200/30—Foods, ingredients or supplements having a functional effect on health
    • A23V2200/318—Foods, ingredients or supplements having a functional effect on health having an effect on skin health and hair or coat
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2200/00—Function of food ingredients
    • A23V2200/30—Foods, ingredients or supplements having a functional effect on health
    • A23V2200/32—Foods, ingredients or supplements having a functional effect on health having an effect on the health of the digestive tract
    • A23V2200/3204—Probiotics, living bacteria to be ingested for action in the digestive tract
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2400/00—Lactic or propionic acid bacteria
    • A23V2400/11—Lactobacillus
    • A23V2400/175—Rhamnosus
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2400/00—Lactic or propionic acid bacteria
    • A23V2400/51—Bifidobacterium
    • A23V2400/515—Animalis
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2400/00—Lactic or propionic acid bacteria
    • A23V2400/51—Bifidobacterium
    • A23V2400/531—Lactis
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2400/00—Lactic or propionic acid bacteria
    • A23V2400/51—Bifidobacterium
    • A23V2400/533—Longum
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K2035/11—Medicinal preparations comprising living procariotic cells
    • A61K2035/115—Probiotics

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Polymers & Plastics (AREA)
  • Food Science & Technology (AREA)
  • Nutrition Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Dermatology (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Biotechnology (AREA)
  • Medical Informatics (AREA)
  • Botany (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Physiology (AREA)
  • Biomedical Technology (AREA)
  • Biochemistry (AREA)
  • Animal Husbandry (AREA)
  • Zoology (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicinal Preparation (AREA)
DK17722689.1T 2016-03-21 2017-03-21 Anvendelse af probiotika ved behandling og/eller forebyggelse af psoriasis DK3432899T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP16382122.6A EP3222282A1 (en) 2016-03-21 2016-03-21 Use of probiotics in the treatment and/or prevention of psoriasis
PCT/EP2017/056719 WO2017162683A1 (en) 2016-03-21 2017-03-21 Use of probiotics in the treatment and/or prevention of psoriasis

Publications (1)

Publication Number Publication Date
DK3432899T3 true DK3432899T3 (da) 2021-07-05

Family

ID=55969084

Family Applications (1)

Application Number Title Priority Date Filing Date
DK17722689.1T DK3432899T3 (da) 2016-03-21 2017-03-21 Anvendelse af probiotika ved behandling og/eller forebyggelse af psoriasis

Country Status (26)

Country Link
US (1) US10912802B2 (da)
EP (2) EP3222282A1 (da)
KR (1) KR102303587B1 (da)
CN (1) CN110325198B (da)
AR (1) AR107921A1 (da)
AU (1) AU2017238300A1 (da)
BR (1) BR112018069284A2 (da)
CA (1) CA3018625A1 (da)
DK (1) DK3432899T3 (da)
EA (1) EA201891908A1 (da)
ES (1) ES2873889T3 (da)
HR (1) HRP20211173T1 (da)
HU (1) HUE055635T2 (da)
IL (1) IL261932B2 (da)
MA (1) MA43488B1 (da)
MX (1) MX2018011593A (da)
MY (1) MY193275A (da)
PE (1) PE20190432A1 (da)
PH (1) PH12018502042A1 (da)
PL (1) PL3432899T3 (da)
PT (1) PT3432899T (da)
RS (1) RS62101B1 (da)
RU (1) RU2767967C2 (da)
SI (1) SI3432899T1 (da)
UA (1) UA127180C2 (da)
WO (1) WO2017162683A1 (da)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT201800002052A1 (it) 2018-01-26 2019-07-26 Girolamo Stefano Di Probiotico per il trattamento della psoriasi
EP3851115A1 (en) * 2020-01-15 2021-07-21 Biopolis, S.L. Probiotic composition for its use as an antioxidant
US20210275612A1 (en) * 2020-03-09 2021-09-09 Glac Biotech Co., Ltd. Method for alleviating inflammation-related disorder
CN113142554A (zh) * 2020-06-09 2021-07-23 江苏佰澳达生物科技有限公司 一种改善头皮屑产生的益生菌发酵液及其应用
EP3967318A1 (en) * 2020-09-14 2022-03-16 Bionou Research, S.L. Probiotic compositions for the treatment of acne
CN112159778B (zh) * 2020-09-30 2021-12-03 江南大学 一株可缓解银屑病的动物双歧杆菌及其应用
WO2022090474A1 (en) * 2020-10-29 2022-05-05 Deerland Probiotics & Enzymes A/S Microencapsulated microbial composition
CN112546074B (zh) * 2020-12-24 2022-09-27 江南大学 一株能够抑制IL-23、Th17轴相关炎症因子释放的短双歧杆菌及其应用
CN112812989B (zh) * 2020-12-31 2022-06-10 江南大学 一种能够缓解银屑病的青春双歧杆菌及其应用
CN113088473B (zh) * 2021-04-27 2022-08-02 江南大学 一株具有缓解HaCaT细胞氧化损伤作用的动物双歧杆菌
CN113455549B (zh) * 2021-06-29 2022-09-13 黑龙江飞鹤乳业有限公司 一种奶酪产品及其制备方法和应用
WO2023111270A1 (en) * 2021-12-16 2023-06-22 Biopolis, S. L. Use of postbiotics in the treatment and/or prevention of anxiety disorders

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BR0307839A (pt) * 2002-02-21 2004-12-07 Nestle Sa Composição fotoprotetora para a pele que pode ser administrada por via oral
JP2004250337A (ja) 2003-02-18 2004-09-09 Sunstar Inc アレルギー疾患改善用製剤
HUE030542T2 (en) * 2005-10-06 2017-05-29 Probi Ab Use of Lactobacillus to treat viral infections
CN101384269B (zh) * 2005-10-06 2012-11-14 普罗比公司 乳酸杆菌用于治疗病毒感染的用途
ES2343499B1 (es) * 2007-12-24 2011-06-10 Consejo Superior De Investigaciones Cientificas Microorganismos para mejorar el estado de salud de individuos con desordenes relacionados con la ingesta de gluten.
DK2704704T3 (da) * 2011-05-03 2019-01-14 Dupont Nutrition Biosci Aps Probiotiske bakterier til topisk behandling af hudlidelser
KR20130049554A (ko) 2011-11-04 2013-05-14 주식회사 쎌바이오텍 아토피 예방 또는 치료용 조성물
KR101453982B1 (ko) * 2012-09-19 2014-10-28 주식회사 쎌바이오텍 과민성 대장 증후군 예방 또는 치료용 조성물
ES2526986B1 (es) * 2013-07-18 2015-11-02 Biopolis, S.L. Nueva cepa de Bifidobacterium animalis subsp. lactis CECT 8145 y su uso para el tratamiento y/o prevención de sobrepeso y obesidad y enfermedades asociadas
KR101724601B1 (ko) 2014-11-04 2017-04-10 주식회사 쎌바이오텍 아토피 예방 또는 치료용 조성물
ES2575828B1 (es) * 2014-12-31 2017-07-07 Universidad De León Empleo de probióticos en el incremento de la fertilidad masculina
TWI829098B (zh) * 2015-01-02 2024-01-11 美商梅拉洛伊卡公司 細菌組成物

Also Published As

Publication number Publication date
ES2873889T3 (es) 2021-11-04
EP3432899A1 (en) 2019-01-30
EA201891908A1 (ru) 2019-04-30
IL261932B (en) 2022-12-01
US10912802B2 (en) 2021-02-09
MX2018011593A (es) 2020-01-30
KR102303587B1 (ko) 2021-09-17
RU2018136939A (ru) 2020-04-22
MY193275A (en) 2022-09-29
MA43488A1 (fr) 2019-12-31
PT3432899T (pt) 2021-07-05
IL261932A (en) 2018-10-31
PE20190432A1 (es) 2019-03-21
UA127180C2 (uk) 2023-05-31
HRP20211173T1 (hr) 2021-10-15
EP3222282A1 (en) 2017-09-27
WO2017162683A1 (en) 2017-09-28
IL261932B2 (en) 2023-04-01
CA3018625A1 (en) 2017-09-28
AR107921A1 (es) 2018-06-28
RU2767967C2 (ru) 2022-03-23
CN110325198B (zh) 2024-04-30
AU2017238300A1 (en) 2018-11-01
PH12018502042A1 (en) 2019-07-15
RS62101B1 (sr) 2021-08-31
PL3432899T3 (pl) 2021-11-22
HUE055635T2 (hu) 2021-12-28
BR112018069284A2 (pt) 2019-03-06
SI3432899T1 (sl) 2021-12-31
EP3432899B1 (en) 2021-04-28
MA43488B1 (fr) 2020-10-28
KR20190008849A (ko) 2019-01-25
US20190328799A1 (en) 2019-10-31
RU2018136939A3 (da) 2020-05-13
CN110325198A (zh) 2019-10-11

Similar Documents

Publication Publication Date Title
DK3432899T3 (da) Anvendelse af probiotika ved behandling og/eller forebyggelse af psoriasis
DK3612517T3 (da) Bicykliske forbindelser og deres anvendelse ved behandling af cancer
DK3149019T3 (da) Cholan-derivater til anvendelse ved behandling og/eller forebyggelse af FXR- og TGR5/GPBAR1-formidlede sygdomme
DK3484585T3 (da) Anvendelse af probiotika ved behandling og/eller forebyggelse af atopisk dermatitis
DK3445388T3 (da) Materialer og fremgangsmåder til behandling af hæmoglobinopatier
DK3325488T3 (da) Chiral diaryl-makrocyklus og anvendelse deraf til behandling af cancer
DK3395359T3 (da) Plasminogen til anvendelse til forebyggelse eller behandling af akut trombose og kronisk trombose
DK3416957T3 (da) 6-heterocyclyl-4-morpholin-4-ylpyridin-2-on-forbindelser anvendelige ved behandlingen af cancer og diabetes
GB201411496D0 (en) Use of 7-Oh-Cannabidiol (7-Oh-CBD) and/or 7-Oh-Cannabidvarin (7-Oh-CBDV) in the treatment of epilepsy
DK3481846T3 (da) 11-substituerede 24-hydroxysteroler til anvendelse til behandling af nmda-relaterede tilstande
DK3273995T3 (da) Kombineret anvendelse af alginatoligomerer og cftr-modulatoren lumacaftor i behandlingen af tilstande associeret med cftr-dysfunktion
DK3442513T3 (da) Anvendelse af cannabidiolsyre i behandling af autismespektrumforstyrrelse og forbundne forstyrrelser
DK3362449T3 (da) Sibirilin-derivater til anvendelse til at forebygge og/eller behandle lidelser associeret med cellulær nekroptose
IL282836A (en) 5-halouracil - modified micro RNAs and their use in cancer treatment
DK3174559T3 (da) Radiomærkede antistoffragmenter til anvendelse inden for forebyggelsen og/eller behandlingen af cancer
DK3532064T3 (da) Kombinationsbehandlinger omfattende imidazopyrazinoner til behandlingen af psykiatriske og/eller kognitive lidelser
DK3790879T3 (da) Triazolopyrimidinforbindelser og deres anvendelse til behandling af kræft
DK3153511T3 (da) 2-acylaminothiazolderivat til anvendelse i forebyggelsen eller behandlingen af blære- og urinvejssygdomme
DK3442547T3 (da) Lactobacillus reuteri MM4-1A til anvendelse i behandling eller forebyggelse af autismespektrumforstyrrelser
DK3326635T3 (da) Behandling og forebyggelse af forkølelse ved hjælp af povidon-iod
DK3678692T3 (da) Genotypestratificering ved behandling og forebyggelse af diabetes
EP3541185C0 (en) USE OF 2-HYDROXYBENZYLAMINE IN THE TREATMENT AND PREVENTION OF PULMONARY HYPERTENSION
DK3258964T3 (da) Detektion og behandling af maligne tumorer i CNS
DK3177599T3 (da) Fumarat-analoger og anvendelser heraf ved behandling af en autoimmun sygdom eller en inflammatorisk sygdom
DK3373922T3 (da) Sammensætninger og fremgangsmåder til anvendelse i behandlingen af homocystinuri